Breast Cancer Res Treat (2017) 165:247–260 DOI 10.1007/s10549-017-4317-2 REVIEW Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers 1 1 1 2,3,4,5,6 • • • • Cheryl Lin Rachel Clark Pikuei Tu Hayden B. Bosworth 2,3,4 Leah L. Zullig Received: 15 April 2017 / Accepted: 24 May 2017 / Published online: 1 June 2017 Springer Science+Business Media New York 2017 Abstract following: (1) OAMs for breast cancer; (2) medication Purpose In the past decade, there has been an increase in adherence; and (3) at least one psychosocial aspect of the development and use of oral anti-cancer medications adherence. (OAMs), especially for breast cancer–the most prevalent Results Of the 1752 papers screened, 21 articles were cancer in women. However, adherence rates for OAMs are included and analyzed. The most commonly reported often suboptimal, leading to lower survival rate, increased motivators for adherence are patient-provider relationships risk of recurrence, and higher healthcare costs. Our goal (n = 11 studied, 82% reported signiﬁcant association) and was to identify potentially modiﬁable psychosocial facili- positive views and beliefs of medication (n = 9 studied, tators and barriers that may be targeted to increase OAM 89% reported signiﬁcant association). We
Breast Cancer Research and Treatment – Springer Journals
Published: Jun 1, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera